HCC
CME icon

Hirtle Callaghan & Co’s CME Group CME Stock Holding History

Hirtle Callaghan & Co’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,050
Closed -$145K – 571
2014
Q2 		$145K Sell
2,050
-1,600
-44% -$113K 0.02% 264
2014
Q1 		$270K Hold
3,650
– – 0.04% 197
2013
Q4 		$296K Buy
3,650
+2,600
+248% +$204K 0.04% 189
2013
Q3 		$78K Buy
+1,050
New +$77.4K 0.01% 302

Other funds holding CME

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return

Hirtle Callaghan & Co's CME Position: Q3 2014 in Review

Hirtle Callaghan & Co sold out of CME Group (CME) in Q3 2014, closing a stake of 2,050 shares — an estimated $145K sold.

Hirtle Callaghan & Co first reported a position in CME in Q3 2013 and held it in 4 quarters. The position peaked at $296K in Q4 2013. 543 funds tracked by Wall St. Rank hold CME as of Q3 2014.

  • Hirtle Callaghan & Co reported no remaining CME Group position as of Q3 2014 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 2,050 CME Group shares in Q3 2014, an estimated $145K.
  • Hirtle Callaghan & Co first reported a position in CME Group in Q3 2013 and held it in 4 quarters.
  • Hirtle Callaghan & Co's CME Group position peaked at $296K in Q4 2013.
  • 543 funds tracked by Wall St. Rank held CME Group as of Q3 2014.

Based on Hirtle Callaghan & Co's 13F filing for Q3 2014, filed 29 Oct 2014.